Synthesis of Chiral 2-Hydroxy-1-methylpropanoates
FULL PAPERS
7.2 Hz, 3H, CH3); 13C NMR (CDCl3): d=175.5 (C=O),
148.9 (arom. =C), 147.4 (arom. =C), 127.4 (arom. =CH),
123.5 (arom. =CH), 75.0 (CHO), 52.0 (OCH3), 46.7 (CH),
14.1 (CH3); MS (EI, 70 eV): m/z=239 [M+, 2], 152
[C7H6NO3 , 21]; 88 [C4H8O2 , 100], HPLC analysis: Chiral-
pak AS-H (150ꢃ4.6 mm), flow rate 1.20 mL/min; eluant
hexane/2-propanol=85:15, tR =6.8 min (2S,3R)-(+)-5b and
tR =9.2 min (2R,3S)-(À)-5b at 210, 240 and 270 nm.
General Procedure for Synthesis of Racemates of 3a,
b and 4a-e
A solution of substrates 2a, b or 4a–e (0,5 mmol) and achiral
[RhACHTUNGTRENNUNG(dppb)ACHTUNGTRENNUNG(COD)]BF4 (3.5 mg, 0.005 mmol) in methanol
+
+
(7.5 mL) was stirred at ambient temperature under a hydro-
gen pressure of 60 bar for 20 h. After decompression the
mixture was directly used for HPLC analysis and the residue
after evaporation was investigated by NMR. In all cases full
conversion was observed.
anti-5b’: mp 1548C; Rf =0.13 (heptane:AcOEt=2:1);
1H NMR (CDCl3): d=7.11 (m, 2H, arom. H), 6.65 (m, 2H,
arom. H), 4.63 (d, J=9.0 Hz, 1H, CHO), 3.73 (s, 3H,
OCH3), 3.67 (s, br, 1H, OH), 2.76 (m, 1H, CH), 0.95 (d, J=
7.2 Hz, 3H, CH3); 13C NMR (CDCl3): d=176.5 (C=O),
146.3 (arom. =C), 131.5 (arom. =C), 127.8 (arom. =CH),
115.0 (arom. =CH), 76.3 (CHO), 51.9 (OCH3), 47.2 (CH),
14.5 (CH3); MS (EI, 70 eV): m/z=209 [M+, 8], 191
[(MÀH2O, 40)+ 122 [C7H8NO+, 100]; HPLC analysis: Chir-
alpak AS-H (150ꢃ4.6 mm), flow rate 1.20 mL/min; eluant
hexane/2-propanol=85:15, tR =11.9 min (2S,3R)-(+)-5b’ and
tR =15.6 min (2R,3S)-(À)-5b’ at 210, 240 and 270 nm.
1
rac-Methyl 3-hydroxy-2-methyl-propanoate (3a): H NMR
(CDCl3): d=3.68 (m, 2H, CH2O), 3.68 (s, 3H, OCH3), 2.65
(m, 1H, CH), 2.50 (s, br, 1H, OH), 1.14 (d, J=7.2 Hz, 3H,
CH3; 13C NMR (CDCl3): d=176.1 (C=O), 64.5 (CH2O), 51.8
(OCH3), 41.6 (CH), 13.4 (CH3); HPLC analysis: Chiralcel
OD-H (150ꢃ4.6 mm), flow rate 1.20 mL/min; eluant
hexane/2-propanol=97:3, tR =5.8 min (R)-3a and tR =
6.6 min (S)-3a at 210, 215 and 225 nm.
rac-tert-Butyl
3-hydroxy-2-methyl-propanoate
(3b):
1H NMR (CDCl3): d=3.63 (m, 2H, CH2O), 2.55 (m, 1H,
CH), 2.44 (s, br, 1H, OH), 1.44 (s, 9H, CH3),1.11 (d, J=
7.2 Hz, 3H, CH3); 13C NMR (CDCl3): d=175.1 (C=O), 80.8
(C-O), 64.6 (CH2O), 42.4 (CH), 28.0 (CH3), 13.5 (CH3);
HPLC analysis: Chiralcel OD-H (150ꢃ4.6 mm), flow rate
1.20 mL/min; eluant hexane/2-propanol=99:1, tR =5.5 min
(R)-3b and tR =6.1 min (S)-3b at 210, 215 and 225 nm.
Application of Pd/C (5%) as catalyst (1 bar, 90 min, S:C=
100:1, THF, 258C) leads to the predicted formation of a
mixture of the anti-5b’ and syn-5b’ diastereomers with a
ratio of 56:44 (84%). In contrast to the observation of
Coelho et al.[17a] we observed also the hydrogenolysis of the
À
C OH bond to form the racemic methyl 3-(4-aminophenyl)-
2-methylpropanoate (5b’’) (16%). All products could be sep-
arated by colum chromatography (heptane:AcOEt=2:1).
syn-5b’: mp 898C; Rf =0.16 (heptane:AcOEt=2:1);
1H NMR (CDCl3): d=7.07 (m, 2H, arom. H), 6.60 (m, 2H,
arom. H), 4.88 (d, J=4.7 Hz, 1H, CHO), 3.60 (s, 3H,
OCH3), 3.60 (s, br, 1H, OH), 2.72 (m, 1H, CH), 1.13 (d, J=
6.7 Hz, 3H, CH3); 13C NMR (CDCl3): d=176.0 (C=O),
145.7 (arom. =C), 131.6 (arom. =C), 127.0 (arom. =CH),
114.9 (arom. =CH), 73.8 (CHO), 51.7 (OCH3), 46.7 (CH),
11.3 (CH3); HPLC analysis: Chiralpak AS-H (150ꢃ4.6 mm),
flow rate 1.20 mL/min; eluant hexane/2-propanol=85:15,
tR =8.5 min (S,S)-(À)-5b’ and tR =13.7 min (R,R)-(+)-5b’ at
210, 240 and 270 nm;
rac-Methyl 3-Hydroxy-2-methyl-3-phenyl-propanoate
(5a) [anti:syn=90:10]
1
anti-5a: H NMR (CDCl3): d=7.23–7.38 (m, 5H, arom. H),
4.72 (d, J=8.8 Hz, 1H, CHO), 3.70 (s, 3H, OCH3), 3.09 (s,
br, 1H, OH), 2.80 (m, 1H, CH), 0.97 (d, J=7.2 Hz, 3H,
CH3); 13C NMR (CDCl3): d=176.3 (C=O), 145.6 (arom. =
C), 128.4 (arom. =CH), 128.0 (arom. =CH), 126.6 (arom.=
CH), 76.4 (CHO), 51.9 (OCH3), 47.1 (CH), 14.4 (CH3);
HPLC analysis: Reprosil 100 NR 8 mm (250ꢃ4.6 mm), flow
rate 1.00 mL/min; eluant hexane/2-propanol=95:5, tR =
8.8 min (2R,3S)-(À)-5a and tR =10.5 min (2S,3R)-(+)-5a at
210, 215 and 225 nm.
rac-5b’’: oil; Rf =0.32 (heptane:AcOEt=2:1); 1H NMR
(CDCl3): d=6.93 (m, 2H, arom. H), 6.60 (m, 2H, arom. H),
3.62 (s, 3H, OCH3), 3.57 (s, br, 1H, OH), 2.90 (dd, J=13.2,
6.6 Hz, 1H, Hb-CH2), 2.65 (m, 1H, CH), 2.54 (dd, J=13.2,
7.6 Hz, 1H, Ha-CH2),1.11 (d, J=6.8 Hz, 3H, CH3);
13C NMR (CDCl3): d=176.8 (C=O), 144.6 (arom. =C), 129.7
(arom. =CH), 129.3 (arom. =C), 115.1 (arom. =CH), 51.5
(OCH3), 41.7 (CH), 38.9 (CH2), 16.6 (CH3); MS (EI, 70 eV):
m/z=193 [M+, 12], 106 [C7H8N+, 100]; HPLC analysis:
Chiralpak AS-H (150ꢃ4.6 mm), flow rate 1.20 mL/min;
eluant hexane/2-propanol=85:15, tR =4.3 min rac-5b’’ at
220, 240 and 255 nm and Chiralcel OD-H (150ꢃ4.6 mm),
flow rate 1.20 mL/min, eluant hexane/2-propanol=85:15,
tR =8.8 min (S)-(+)-5b’’ and tR =11.0 min (R)-(À)-5b’’ at
220, 240 and 255 nm.
syn-5a: 1H NMR (CDCl3): d=7.23–7.38 (m, 5H, arom.
H), 5.06 (d, J=4.3 Hz, 1H, CHO), 3.64 (s, 3H, OCH3), 3.09
(s, br, 1H, OH), 2.80 (m, 1H, CH), 1.11 (d, J=7.2 Hz, 3H,
CH3); 13C NMR (CDCl3): d=176.1 (C=O), 141.4 (arom. =
C), 128.2 (arom. =CH), 127.4 (arom. =CH), 125.9 (arom. =
CH), 73.6 (CHO), 51.8 (OCH3), 46.4 (CH), 10.7 (CH3);
HPLC analysis: Reprosil 100 NR 8 mm (250ꢃ4.6 mm), flow
rate 1.00 mL/min; eluant hexane/2-propanol=95:5, tR =
7.6 min and tR =8.0 min syn-5a at 210, 215 and 225 nm.
Racemic anti-Methyl 3-Hydroxy-2-methyl-3-(4-nitro-
phenyl)propanoate (5b), rac-Methyl 3-(4-
Aminophenyl)-3-hydroxy-2-methylpropanoate (5b’)
and rac-Methyl 3-(4-Aminophenyl)-2-
methylpropanoate (5b’’) [anti-5b:anti-5b’=89:11]
rac-Methyl 3-Hydroxy-2-methyl-3-(4-methyl-
phenyl)propanoate (5c) [anti:syn=97:3]
Separation by chromatography (eluant heptane:AcOEt=
2:1 to 1:1).
anti-5b: mp 1058C; Rf =0.32 (heptane:AcOEt=2:1);
1H NMR (CDCl3): d=8.13 (m, 2H, arom. H), 7.45 (m, 2H,
arom. H), 4.81 (d, J=7.7 Hz, 1H, CHO), 3.67 (s br, 1H,
OH), 3.64 (s, 3H, OCH3), 2.76 (m, 1H, CH), 1.00 (d, J=
1
anti-5c: H NMR (CDCl3): d=7.19 (m, 2H, arom. H), 7.13
(m, 2H, arom. H), 4.67 (d, J=8.5 Hz, 1H, CHO), 3.70 (s,
3H, OCH3), 3.04 (s, br, 1H, OH), 2.77 (m, 1H, CH), 2.32 (s,
3H, CH3), 0.95 (d, J=7.2 Hz, 3H, CH3); 13C NMR (CDCl3):
Adv. Synth. Catal. 2008, 350, 2533 – 2543
ꢂ 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2541